Pharmasset Inc. (VRUS) Stock Quote

Detailed Quote for Pharmasset Inc. (VRUS)

close 52 Week Information

52 Week High

January 17, 2012

Close: 137.01

52 Week Low

February 8, 2011

Close: 23.245

Today

Last Price
N/A

Change $
N/A

Change %
N/A

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
N/A

High
N/A

Low
N/A

Prev Close
N/A

Last Trade
N/A

Volume
0

52 Wk Hi
137.01

52 Wk Low
23.245

Market Cap
N/A

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
75,657,230

EPS (TTM)
-1.25

PE Ratio
N/A

close Exchange Information Listed On Nasdaq Global Select (NGS) Exchange
NGS

News and Media for Pharmasset Inc. (VRUS)

Sector News | Topic News

News for VRUS

Tue, Jan 17, 2012

5:00 PM

Gilead Sciences Completes Acquisition of Pharmasset, Inc. - Business Wire

Thu, Jan 12, 2012

1:25 AM

Gilead Sciences Completes Tender Offer for All Outstanding Shares of Pharmasset, Inc. - Business Wire

Mon, Dec 19, 2011

7:30 AM

Coronado Biosciences to Begin Trading on NASDAQ Today - Marketwire

Fri, Dec 16, 2011

8:00 AM

Pharmasset Announces Intent to Amend QUANTUM Trial - PR Newswire

Wed, Dec 07, 2011

9:00 AM

A Change in Tides - Featured Research on AutoZone, Inc. and Pharmasset, Inc. - Marketwire

Wed, Nov 30, 2011

10:00 PM

Bull & Lifshitz, LLP Announces Investigation of Pharmasset, Inc. - Business Wire

Tue, Nov 22, 2011

9:01 AM

Direction of Market Influences - Report Highlights BMC Software, Inc. and Pharmasset, Inc. - Marketwire

Mon, Nov 21, 2011

7:36 PM

Ryan & Maniskas, LLP Announces Investigation of Pharmasset, Inc. - Business Wire

7:06 PM

The Law Firm of Weiss & Lurie Investigates Pharmasset, Inc. - Business Wire

6:27 PM

Pomerantz Law Firm Investigates Claims on Behalf of Investors of Pharmasset, Inc. - Business Wire

3:39 PM

Pharmasset, Inc. Shareholder Alert: The Briscoe Law Firm and Powers Taylor, LLP Investigate the Board of Pharmasset, Inc. Concerning the Sale of Pharmasset to Gilead Sciences, Inc. - PR Newswire

2:54 PM

The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Pharmasset, Inc. in Connection with the Sale of the Company to Gilead Sciences, Inc. - PR Newswire

12:29 PM

Rigrodsky & Long, P.A. Announces Investigation of Pharmasset, Inc. - Business Wire

7:00 AM

Gilead Sciences to Acquire Pharmasset, Inc. for $11 Billion - Business Wire

Mon, Nov 14, 2011

5:11 PM

Pharmasset Reports Fiscal Year End 2011 Financial Results - PR Newswire

Sun, Nov 13, 2011

8:44 PM

Pharmasset to Present at the Lazard Capital Markets Healthcare Conference - PR Newswire

Tue, Nov 08, 2011

5:03 PM

Pharmasset to Present at Credit Suisse First Boston Healthcare Conference - PR Newswire

Fri, Nov 04, 2011

7:30 AM

Pharmasset to Webcast an Investor Event from the AASLD Meeting - PR Newswire

7:00 AM

New 12 Week, Interferon-Free Treatment Arms Added to All-Oral Combination Study of PSI-7977 and Daclatasvir (BMS-790052) for HCV Genotype 1 - PR Newswire

Tue, Nov 01, 2011

6:00 AM

Pharmasset Announces the Initiation of an Interferon-Free Phase 3 Program with PSI-7977 for HCV - PR Newswire

More News for VRUS >>

Tags for Pharmasset Inc.

Research stocks or mutual funds related to Pharmasset Inc. by keywords or tags. Find companies that have a similar focus to VRUS. The keywords below have been associated to VRUS by either user submission or electronic means.

biotechnology company stock trading financial ratio analysis corporate financial starbucks stock information map chest financial annual report laminated world map corporate secretary software annual report pharmaceutical supplies corporate governance investor relations service pharmaceuticals jobs pharma license pepsi stock symbol novartis pharmaceuticals financial report corporate travel center pharmaceutical class stock report investor relations data map anaheim hotel board of directors role pharmaceutical sales pharma stock returns world map posters biotech corporation minsk street map Drugs annual report of company corporate annual report investor relations information pepsi stock stock market report financial stock report board of directors info starbucks stock symbol pharmaceutical article pfizer pharmaceuticals pepsi annual report pharmaceutical events biotech investment board of directors responsibility pharmaceutical sale pharmaceutical business development Healthcare oil and gas investments bio pharmaceuticals